Wird geladen...
Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
OBJECTIVES: To evaluate the efficacy of intravitreal bevacizumab treatment in type 2 idiopathic macular telangiectasia (IMT). MATERIALS AND METHODS: Six eyes of 5 patients with type 2 IMT who received intravitreal bevacizumab between 2009 and 2014 were included in this study. All the patients had an...
Gespeichert in:
| Veröffentlicht in: | Turk J Ophthalmol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Galenos Publishing
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5177783/ https://ncbi.nlm.nih.gov/pubmed/28050323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjo.23921 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|